Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04332614 · ClinicalTrials.gov registry record
Email Campaign to Increase Uptake of myGeisinger
A clinical trial, sponsored by Geisinger Clinic.
- Completed
- Registry status
- 14,099
- Enrollment target
NCT04332614: Completed study, sponsored by Geisinger Clinic.
NCT04332614 is a clinical trial that has completed, run by Geisinger Clinic. The registered enrollment target is 14,099 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04332614 has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- 14,099 participants
- Enrollment target
Study Summary
The purpose of the current study is to test different email messages to determine the most effect way of promoting enrollment in Geisinger's patient portal, called myGeisinger.
Primary Outcome
Whether email was opened (yes / no)
Interventions
- BEHAVIORAL Less-is-better
- BEHAVIORAL Social proof
- BEHAVIORAL Endowment / decision staging
- BEHAVIORAL Standard email
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,099 participants |
| Start Date | 2020-04-06 |
| Est. Completion | 2020-05-08 |
What the finished NCT04332614 record still lists
NCT04332614 is an observational study that tracks outcomes without assigning an intervention. Its 14,099 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which Less-is-better is the first listed.
NCT04332614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04332614 about?
NCT04332614 is a clinical study titled "Email Campaign to Increase Uptake of myGeisinger". The purpose of the current study is to test different email messages to determine the most effect way of promoting enrollment in Geisinger's patient portal, called myGeisinger.
What is the current status of trial NCT04332614?
This trial is currently completed. The enrollment target is 14,099 participants. The study started on 2020-04-06. Estimated completion is 2020-05-08.
What interventions are being tested in trial NCT04332614?
The interventions under investigation include: Less-is-better (BEHAVIORAL), Social proof (BEHAVIORAL), Endowment / decision staging (BEHAVIORAL), Standard email (BEHAVIORAL).
Who is sponsoring clinical trial NCT04332614?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI